Skip to content

The Effect of HIIT, MICT in Patients With Myocardial Infarction

Effect of High-Intensity Interval Training, Moderate Continuous Training, or Guideline-Based Physical Activity on Peak Oxygen Uptake and Myocardial Fibrosis in Patients With Myocardial Infarction: Protocol for a Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04863677
Enrollment
188
Registered
2021-04-28
Start date
2021-05-01
Completion date
2025-09-30
Last updated
2026-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiopulmonary Disease, Myocardial Infarction, Training Group, Sensitivity

Keywords

High Intensity Intermittent Training, Myocardial Infarction, Moderate Intensity Continuous Training, Cardiac Rehabilitation, Cardiopulmonary exercise testing

Brief summary

This study will investigate the effect of a 12-weeks cardiac rehabilitation training (HIIT, MICT) program on VO2peak and cardiac fibrosis in patients, and evaluate the effects of HIIT on endothelial function, microvascular obstruction, body fat, inflammation, arrhythmia and psychology .

Detailed description

Eligible and consenting patients are randomized (block randomization) in a 1:1:1 ratio. According to the number of 180 samples calculated by the sample size, the random number table containing 1-180 ( including shedding cases ) was obtained by the computer. Case number will be assigned to participants in each group according to the order of grouping, and each case number corresponded to Group1(HIIT), 2(MICT) or 3(Control) according to the random number. The HIIT sessions include brief, intermittent bouts of high-intensity exercise interspersed with periods of low-intensity exercise (active recovery). HIIT include 20 intervals of high-intensity (30-60s at rating of perceived exertion (RPE; Borg scale of 6-20) of 15 to 17) and low-intensity (1min at RPE \<10 or totally rest). The whole exercise cycle takes around 40-50 minutes (Figure 2). In MICT Group, patients perform 40-50 minutes at a RPE of 12 to 14(a total of 4 groups, each group 5-8 min, interspersed with 2-minute rest)(Figure 3). HIIT and MICT are performed only during supervised sessions with non-consecutive 3 days/week. And all patients are supervised by professional CR team. After assessing by therapists and doctors, participants also can perform three days of home-based exercises guided by wearing a sports bracelet. The CR program includes 36 sessions supervised exercises, pharmacological counseling, patient education, catering management, smoking cessation counseling, stress management, and psychological counseling. A standard 36 sessions of CR usually lasts 12 weeks (three sessions per week).

Interventions

BEHAVIORALHigh Intensity Interval Training(HIIT)

Last 12 weeks (3 sessions per week)

BEHAVIORALModerate Intensity Continuous Training(MICT)

Moderate Intensity Continuous Training(MICT)

Sponsors

Guangdong Provincial People's Hospital
Lead SponsorOTHER
Zhongshan Hospital Of Traditional Chinese Medicine
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Aged 18 -75 years 2. Acute myocardial infarction (AMI) patients between 6 weeks and 3 months and had been underwent revascularization, and New York Heart Association functional classification (NYHA) Class I-III; (AMI confirmed by the World Health Organization definition (presence of symptoms of ischemia and changes in electrocardiogram) or the Third Universal Definition of Myocardial Infarction (elevation of a cardiac biomarker along with presence of either symptoms of myocardial infarction or changes in electrocardiogram)) 3. Willing and able to attend the complete cardiac rehabilitation(CR)program on their own,assigned the Informed consent form. 4. Complete the cardiopulmonary exercise testing (CPET) at enrollment or has the CPET report within 1 month.

Exclusion criteria

1. High-intensity exercise frequently 2. Currently participating in any other clinical trials 3. Have any other diseases which limit their life to less than a year (e.g. severe valvular disease, recurrent ventricular arrhythmias, NYHA Class IV heart failure, severe aortic incompetence, severe atrial fibrillation, cancers, and end-stage renal or liver disease) 4. Dementia ; disability or sports contraindication 5. Severe acute liver failure 6. Severe acute renal failure 7. Unstable vital signs 8. Site investigators consider that the patient will be unable to complete the study and/or attend for follow-up.

Design outcomes

Primary

MeasureTime frameDescription
The effect of HIIT/MICT on VO2peak3 monthsChanges in VO2peak after 3-month cardiac rehabilitation training ( HIIT, MICT), assessed by cardiopulmonary exercise testing.
Evaluate the degree of cardiac fibrosis in 3 groups by cardiac magnetic resonance3 monthsThe effect of HIIT/MICT on myocardial fibrosis in patients with MI, assessed by cardiac magnetic resonance.

Secondary

MeasureTime frameDescription
The effect of HIIT/MICT on endothelial function as assessed by the Endo-PAT20003 monthsEndothelial function will be assessed using the Endo-PAT2000 (Itamar Medical), which measures the finger pulse volume amplitude (PVA) using volume plethysmography technology to reflect peripheral blood volume changes.
The effect of HIIT/MICT on body circumference3 monthsThe effect of HIIT/MICT on body circumference
The effect of HIIT/MICT on quality of life as assessed by SF-363 monthsThe effect of HIIT/MICT on quality of life as assessed by SF-36
The effect of HIIT and MICT on depressionBaseline and 3monthsDepression is assessed by Patient Health Questionnaire - 9 (PHQ-9)
The effect of HIIT and MICT on anxietyBaseline and 3monthsAnxiety is assessed by General anxiety disorder-7 (GAD-7)

Countries

China

Contacts

STUDY_CHAIRQingshan Geng

Guangdong Provincial People's Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026